Genentech, Inc.
1 DNA Way
South San Francisco
California
94080-4990
United States
Tel: 650-225-1000
Fax: 650-225-6000
Website: http://www.gene.com/
About Genentech, Inc.
Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for over 40 years. Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. We are among the world's leading biotech companies, with multiple products on the market and a promising development pipeline. Please take this opportunity to learn about Genentech where we believe that our employees are our most important asset & are dedicated to remaining a great place to work.
Connect with us!
Being a scientist at Genentech means being a drug discoverer. Mike Varney, head of Genentech Research and Early Development, explains how this culture of innovation is helping to solve some of the hardest biomedical problems of our time.
1437 articles with Genentech, Inc.
-
Drug That Cuts Off Tumor's Blood Supply Extends Lives Of Colorectal Cancer Patients
6/3/2004
-
Big Pharma Could Hog Biotech's Spotlight
6/3/2004
-
Drug Combo Effective For Advanced Breast Cancer
5/19/2004
-
Key Protein In Blood Vessel Formation Found; Could Help Fight Against Heart Disease, Cancer
4/15/2004
-
State Of The Industry
4/12/2004
-
Asthma Drug Improves Allergies Too
3/23/2004
-
New Cancer Drugs Offer Patients Hope, Drug Makers Success
3/2/2004
-
California Biotech Leaders Urge New Growth Policies
2/6/2004
-
Striving To Stop HIV
1/26/2004
-
Atherogenics, Genaera, Pfizer, Genentech, And MedImmune
1/21/2004
-
Top 2003 Stories From The BioSpace NewsBeat
12/31/2003
-
Genentech Proves The Skeptics Wrong; Biotech Firm Reaps Rewards By Trusting Scientific Instincts
12/30/2003
-
Bull's Eye
12/18/2003
-
Another New Drug For Psoriasis
12/17/2003
-
New Drugs Offer Hope For Psoriasis Sufferers
11/20/2003
-
Roche Keen On Genentech-Type Acquisitions
11/6/2003
-
Defending Esperion
11/5/2003